ALS Phase 3 Study Ceftriaxone Treatment Report

Category: Others

false

See also: Clinical Trial

What is ALS Phase 3 Study Ceftriaxone?

An example of ALS Phase 3 Study Ceftriaxone

NCT00349622 is a clinical trial with ceftriaxone in subjects with amyotrophic lateral sclerosis (ALS). Other study IDs include: U01NS049640-02, NINDS, U01NS049640-02, NINDS CRC.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
ALS (Amyotrophic Lateral Sclerosis) 12 11 Efficacy_slight Efficacy_none Efficacy_cant_tell
Participate in clinical trial 9 5 Efficacy_none Efficacy_cant_tell

See all 12 patients currently using ALS Phase 3 Study Ceftriaxone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 4
Mild
 3
None
 6

Commonly reported side effects, conditions, and hospitalizations associated with ALS Phase 3 Study Ceftriaxone

Gallstones 3
Beginning of gallstones 2
Yeast Infection (candida) 2
Oral thrush (candidiasis) 1
Kidney stones 1
Fever 1
See all 18 reported side effects ▼ See top 6 reported side effects ▲

Reported Schedules

  1 other daily 2 mg daily 2 g daily 2 other daily 4 g daily 30 mg daily 50 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Using ALS Phase 3 Study Ceftriaxone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 4   Side effects too severe: 40%
Course of treatment ended 4   Course of treatment ended: 40%
Doctor's advice 3   Doctor's advice: 30%
Did not seem to work 1   Did not seem to work: 10%
Other 1   Other: 10%

See all 10 patients who’ve stopped using ALS Phase 3 Study Ceftriaxone

Reported Duration See details about how long patients take this treatment ▼

Currently Using ALS Phase 3 Study Ceftriaxone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Using ALS Phase 3 Study Ceftriaxone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of ALS Phase 3 Study Ceftriaxone

Always
 13 87%
Usually
 1 7%
Sometimes
 0 0%
Never
 1 7%

Burden

Difficulty being on treatment

Burden of ALS Phase 3 Study Ceftriaxone

Very
 3 20%
Somewhat
 7 47%
A little
 4 27%
Not at all
 1 7%

Cost

Paid out of pocket

Cost of ALS Phase 3 Study Ceftriaxone

$200+
 1 8%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 12 92%

Sort by: Helpfulness | Most Recent

2 patient evaluations for ALS Phase 3 Study Ceftriaxone

Purpose: ALS (Amyotrophic Lateral Sclerosis) (Started Oct 22, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 29, 2011 1 other Daily ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Mar 04, 2011 1 other Daily ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Date
Apr 29, 2011
Advice & Tips
I take this treatment twice a day. People tell me that my ALS is moving slower.
Cost
< $25 monthly
Date
Mar 04, 2011
Advice & Tips
I think this is a good study. We set a time each morning to take the medication, and it is no problem for us. I feel I swallow better when I am on the medication. Taking this medication is an adjustment to my life, but so is ALS and if this is going help me, I'll do it.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks
Purpose: Participate in clinical trial (Started Oct 11, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Dec 20, 2010 2 mg Daily ?Can't tell MildMildMildMildMild UsuallyUsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhatSomewhat
Nov 20, 2010 2 mg Daily Led_efficacy_1Led_defaultLed_defaultLed_defaultNone ModerateModerateModerateModerateModerate UsuallyUsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhatSomewhat
Oct 21, 2010 4 g Daily ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Side effects:
Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive
Date
Dec 20, 2010
Advice & Tips
It's no problem for me, but my husband has so much to do that he forgets to thaw the medicine sometimes.
Cost
< $25 monthly
Date
Nov 20, 2010
Advice & Tips
I feel like I'm getting worse more quickly, but don't know whether it is the study drug or riluzole.
Cost
< $25 monthly
Date
Oct 21, 2010
Advice & Tips
I was afraid that the procedures for administering the drug would be difficult, but it isn't too hard for my husband to do and it is easy to schedule early in the morning and then before bed. I feel good about participating in a trial.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks

13 additional evaluations for ALS Phase 3 Study Ceftriaxone are not currently shared publicly.

Last updated: